Beijing Kawin Technology Share-Holding Future Growth
Future criteria checks 5/6
Beijing Kawin Technology Share-Holding is forecast to grow earnings and revenue by 29.6% and 24% per annum respectively. EPS is expected to grow by 28.7% per annum. Return on equity is forecast to be 10.6% in 3 years.
Key information
29.6%
Earnings growth rate
28.7%
EPS growth rate
Biotechs earnings growth | 34.3% |
Revenue growth rate | 24.0% |
Future return on equity | 10.6% |
Analyst coverage | Low |
Last updated | 25 Apr 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,763 | 268 | 219 | 279 | 4 |
12/31/2025 | 2,196 | 198 | 158 | 277 | 4 |
12/31/2024 | 1,709 | 148 | 123 | 165 | 4 |
3/31/2024 | 1,432 | 118 | 41 | 197 | N/A |
12/31/2023 | 1,412 | 117 | -28 | 127 | N/A |
9/30/2023 | 1,326 | 105 | -36 | 69 | N/A |
6/30/2023 | 1,236 | 85 | -74 | 19 | N/A |
3/31/2023 | 1,181 | 80 | -123 | -13 | N/A |
12/31/2022 | 1,160 | 83 | 59 | 134 | N/A |
9/30/2022 | 1,275 | 98 | 18 | 115 | N/A |
6/30/2022 | 1,184 | 109 | 29 | 109 | N/A |
3/31/2022 | 1,144 | 111 | 55 | 113 | N/A |
12/31/2021 | 1,144 | 107 | 74 | 118 | N/A |
9/30/2021 | 1,033 | 98 | 105 | 133 | N/A |
6/30/2021 | 1,002 | 85 | 108 | 134 | N/A |
3/31/2021 | 912 | 80 | 122 | 150 | N/A |
12/31/2020 | 862 | 76 | 90 | 131 | N/A |
9/30/2020 | 825 | 55 | 114 | 168 | N/A |
12/31/2019 | 825 | 54 | 54 | 103 | N/A |
12/31/2018 | 706 | 45 | 10 | 60 | N/A |
12/31/2017 | 491 | 27 | N/A | 14 | N/A |
12/31/2015 | 268 | 24 | N/A | 8 | N/A |
12/31/2014 | 225 | 12 | N/A | 50 | N/A |
12/31/2013 | 200 | 17 | N/A | 17 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688687's forecast earnings growth (29.6% per year) is above the savings rate (2.9%).
Earnings vs Market: 688687's earnings (29.6% per year) are forecast to grow faster than the CN market (24.4% per year).
High Growth Earnings: 688687's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688687's revenue (24% per year) is forecast to grow faster than the CN market (14.6% per year).
High Growth Revenue: 688687's revenue (24% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688687's Return on Equity is forecast to be low in 3 years time (10.6%).